Lithium use and primary hyperparathyroidism.
OBJECTIVE
To review suspected causes of lithium-induced hyperparathyroidism, disease presentation, underlying pathology, and current recommendations and trends in medical and surgical treatment.


METHODS
Relevant literature was reviewed.


RESULTS
Lithium carbonate therapy has continued to be a mainstay of treatment for bipolar disease and schizoaffective disorder since its introduction into clinical use. Several metabolic consequences are associated with its long-term use, including hypercalcemia and hyperparathyroidism.


CONCLUSIONS
Until further data become available, the surgeon should remain vigilant for the presence of pathologically active glands that may manifest their function at different times during the disease course.
Division of Surgical Oncology and Endocrine Surgery, Department of Surgical Sciences, Vanderbilt University, Nashville, Tennessee 37232-6860, USA. james.broome@vanderbilt.edu
James T
JT
Broome
Carmen C
CC
Solorzano
D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000188:drug therapy* / Q000209:etiology; D016651:Lithium Carbonate / Q000627:therapeutic use*
D016651:Lithium Carbonate